Your browser doesn't support javascript.
loading
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis.
Miyagawa, Sawa; Horie, Takahiro; Nishino, Tomohiro; Koyama, Satoshi; Watanabe, Toshimitsu; Baba, Osamu; Yamasaki, Tomohiro; Sowa, Naoya; Otani, Chiharu; Matsushita, Kazuki; Kojima, Hidenori; Kimura, Masahiro; Nakashima, Yasuhiro; Obika, Satoshi; Kasahara, Yuuya; Kotera, Jun; Oka, Kozo; Fujita, Ryo; Sasaki, Takashi; Takemiya, Akihiro; Hasegawa, Koji; Kimura, Takeshi; Ono, Koh.
Afiliação
  • Miyagawa S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Horie T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan thorie@kuhp.kyoto-u.ac.jp.
  • Nishino T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Koyama S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Watanabe T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Baba O; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yamasaki T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sowa N; Division of Translational Research, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan.
  • Otani C; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsushita K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kojima H; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kimura M; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakashima Y; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Obika S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Kasahara Y; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Kotera J; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Oka K; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Fujita R; Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, Fujisawa-shi, Japan.
  • Sasaki T; Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, Fujisawa-shi, Japan.
  • Takemiya A; Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, Fujisawa-shi, Japan.
  • Hasegawa K; Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, Fujisawa-shi, Japan.
  • Kimura T; Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, Fujisawa-shi, Japan.
  • Ono K; Division of Translational Research, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan.
Life Sci Alliance ; 6(8)2023 08.
Article em En | MEDLINE | ID: mdl-37263777
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article